IDEAS home Printed from https://ideas.repec.org/a/ovi/oviste/vxivy2014i2p119-131.html
   My bibliography  Save this article

A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market

Author

Listed:
  • Margaritti Doina

    (”Ovidius” University of Constanta, Faculty of Pharmacy)

Abstract

Competition in the pharmaceutical industry assures maximum efficiency regarding the use of a company’s capital in comparison to other competitors that have the same sphere of activity. Creating and maintaining a competitive advantage in the pharmaceutical market is achieved through measures, specific methods that are used by companies in the pharmaceutical industry like planning and production strategies, an efficient use of raw materials, innovative research and development activities and through specializing the work force, thus determining a higher efficiency for the players in this field and an increased efficiency obtained by the competing companies. The new competitive advantage concept is based primary on active, selective policies that are directed to achieve certain targets in the pharmaceutical markets competitiveness, which is focused on four pillars: the company, the competition, the favourable national environment and the adequate economic policies that are oriented and applied to the drug producing companies, the state institutions and the European Union organisations.

Suggested Citation

  • Margaritti Doina, 2014. "A New Vision Regarding the Competitive Advantages in the Romanian Pharmaceutical Market," Ovidius University Annals, Economic Sciences Series, Ovidius University of Constantza, Faculty of Economic Sciences, vol. 0(2), pages 119-131, May.
    • Handle: RePEc:ovi:oviste:v:xiv:y:2014:i:2:p:119-131
    as

    Download full text from publisher

    File URL: http://stec.univ-ovidius.ro/html/anale/RO/cuprins%20rezumate/ANALE%20vol%2014%20issue_2_2014.pdf
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Competitive advantage; innovative and generic drugs; research pharmaceutical industry.;
    All these keywords.

    JEL classification:

    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
    • P52 - Political Economy and Comparative Economic Systems - - Comparative Economic Systems - - - Comparative Studies of Particular Economies

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ovi:oviste:v:xiv:y:2014:i:2:p:119-131. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Gheorghiu Gabriela (email available below). General contact details of provider: https://edirc.repec.org/data/feoviro.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.